In a study of head and neck squamous cell carcinoma, CNTNAP2 has some predictive ability for the sensitivity of laryngeal squamous cell carcinoma to induction chemotherapy19. This evidence concerns the gene CNTNAP2 and laryngeal squamous cell carcinoma.